Sri Jay Pharma Exim Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2004.
2004 Mumbai, Maharashtra, India Converted to LLP
Last Updated:
Access Report
About Sri Jay Pharma Exim Private Limited

Sri Jay Pharma Exim Private Limited, a converted to llp private limited company, was established on 17 September 2004 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U51397MH2004PTC148692. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹0.10 M.

Past directors included Shanti Krishnan, Nalini Sheth, Amit Vinod Sheth. Its latest AGM occurred on 29 September 2017, with the balance sheet filed on 31 March 2017. It is based at 114-B Kandivali Industrial Estate Kandivali West, Mumbai, Maharashtra, 400067.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51397MH2004PTC148692

  • Registration Number

    148692

  • Incorporation Date

    17 September 2004

  • Authorized Capital

    ₹3.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Converted to LLP

Key Metrics
  • Authorised Capital ₹ 3.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 21 Year, 5 Months
  • Last Filing with ROC 31 Mar 2017
  • Revenue Growth **** %
  • Profit Growth **** -3594.84%
  • Net Worth -114.74%
  • Total Assets -5.00%
Company report

Sri Jay Pharma Exim Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sri Jay Pharma Exim Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Sri Jay Pharma Exim Private Limited?
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 20 Mar 2010 Past
Pramod Abcsdd Director 01 Mar 2018 Past
Pramod Abcsdd Director 21 Jun 2018 Past
Pramod Abcsdd Director 20 Mar 2010 Past
Pramod Abcsdd Additional Director 21 Jun 2018 Past
Pramod Abcsdd Director 20 Mar 2010 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sri Jay Pharma Exim.

Sri Jay Pharma Exim Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 3594.84% decrease in profit. The company's net worth observed a substantial decline by a decrease of 114.74%.

Sri Jay Pharma Exim revenue growth over time
Sri Jay Pharma Exim profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -5.00%
*******
*******
*******
*******
Profit or Loss
*******
 -3594.84%
*******
*******
*******
*******
Net Worth
*******
 -114.74%
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sri Jay Pharma Exim?

In 2017, Sri Jay Pharma Exim had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Sri Jay Pharma Exim?

Unlock and access historical data on people associated with Sri Jay Pharma Exim, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sri Jay Pharma Exim, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Jay Pharma Exim's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sri Jay Pharma Exim
Recent Activity within the Organization
  • Annual General Meeting

    Sri Jay Pharma Exim Private Limited last Annual general meeting of members was held on 29 Sep 2017 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Sri Jay Pharma Exim Private Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Mumbai. was documented.

  • Company Incorporation

    Progress on Sri Jay Pharma Exim Private Limited was registered on 17 Sep 2004 with Roc Mumbai & aged 21 years 5 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sri Jay Pharma Exim Private Limited?

The CIN of Sri Jay Pharma Exim Private Limited is U51397MH2004PTC148692.

Where is Sri Jay Pharma Exim Private Limited headquartered?

Sri Jay Pharma Exim Private Limited is headquartered at 114-B Kandivali Industrial Estate Kandivali West, Mumbai, Maharashtra, 400067.

When was Sri Jay Pharma Exim Private Limited incorporated?

Sri Jay Pharma Exim Private Limited was incorporated on 17 September 2004.

What is the primary industry of Sri Jay Pharma Exim Private Limited?

The primary industry of Sri Jay Pharma Exim Private Limited is Pharma.

Is Sri Jay Pharma Exim Private Limited a listed company?

Sri Jay Pharma Exim Private Limited is unlisted.

What is the capital structure of Sri Jay Pharma Exim Private Limited?

The authorized capital of Sri Jay Pharma Exim Private Limited is ₹3.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available